| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/28/2013 | US8450472 Isolated nucleic acid molecules encoding bitter taste receptor polypeptides and fragments thereof |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450460 Single-chain TNFSF fusion polypeptides |
| 05/28/2013 | US8450457 T1R taste receptors and genes encoding same |
| 05/28/2013 | US8450289 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 05/28/2013 | US8450112 Engineering and delivery of therapeutic compositions of freshly isolated cells |
| 05/28/2013 | US8450111 Lipid extraction from microalgae using a single ionic liquid |
| 05/28/2013 | US8450110 Human neuronal progenitor cells co-expressing nestin and Pax6, and co-expressing NeuN or Tuj1 |
| 05/28/2013 | US8450108 Surgical device for skin therapy or testing |
| 05/28/2013 | US8450105 Mechanically reversible gel |
| 05/28/2013 | US8450087 Use of triplex structure DNA in transferring nucleotide sequences |
| 05/28/2013 | US8449889 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 05/28/2013 | US8449885 Anti-VEGF antibodies |
| 05/28/2013 | US8449877 Pharmaceutically purified intact bacterial minicells |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2623170C Kit for preparing a composition comprising fat cells |
| 05/28/2013 | CA2556855C Composition and method for enhancing plant transformation and homologous recombination |
| 05/28/2013 | CA2554784C Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/28/2013 | CA2517258C Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications |
| 05/28/2013 | CA2483145C Transgenic plants with controlled distribution of a trait to progeny |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2434802C Isolating cells expressing secreted proteins |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2412239C Cytokine receptor zcytor17 |
| 05/28/2013 | CA2406180C Viruses comprising mutant ion channel protein |
| 05/28/2013 | CA2324513C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 05/28/2013 | CA2280997C Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 05/23/2013 | WO2013074916A1 Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
| 05/23/2013 | WO2013074556A1 Methods of inducing chondrogenesis in mesenchymal stem cells using synthetic triterpenoids |
| 05/23/2013 | WO2013073707A1 Cell culture substrate, and method for manufacturing same |
| 05/23/2013 | WO2013073699A1 Protein having glycoalkaloid biosynthase activity, and gene encoding same |
| 05/23/2013 | WO2013073672A1 Device for manufacturing supporting body for cell structure manufacture |
| 05/23/2013 | WO2013073667A1 Intestinal fibrosis treatment agent |
| 05/23/2013 | WO2013073653A1 Method for inducing proteolysis in eukaryotic cell |
| 05/23/2013 | WO2013073246A1 Method of inducing differentiation from pluripotent stem cells to skeletal muscle cells |
| 05/23/2013 | WO2013072832A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/23/2013 | WO2013072527A1 Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications |
| 05/23/2013 | WO2013072486A1 Mutants of hydantoinase |
| 05/23/2013 | WO2013071871A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 05/23/2013 | WO2013071469A1 Method, kit, and application of applying reverse differentiation to human somatic cells to generate autologous retinal stem cells and autologous retinal cells |
| 05/23/2013 | WO2013071440A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | WO2013049564A3 Ultra-rapid diagnostic tissue preparation as an alternative to frozen section |
| 05/23/2013 | WO2013021389A3 Downregulation of mir-7 for promotion of beta cell differentiation and insulin production |
| 05/23/2013 | WO2012099285A9 Nano ceramic bone cement using animal bones and preparation method thereof |
| 05/23/2013 | US20130133100 Radish cultivar e66v70336 |
| 05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
| 05/23/2013 | US20130131804 Joint Repair Using Mesenchymal Stem Cells |
| 05/23/2013 | US20130131640 Method of creating and sorting fused cells |
| 05/23/2013 | US20130131423 Methods to detect and treat diseases |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131145 COMPOSITIONS AND METHODS FOR ALTERING RNAi |
| 05/23/2013 | US20130130971 Method for Inhibiting HIV Replication in Mammal and Human Cells |
| 05/23/2013 | US20130130388 Methods of Modifying Eurakyotic Cells |
| 05/23/2013 | US20130130384 Temperature responsive sheet that displays reversible properties and cell sheet production method using same |
| 05/23/2013 | US20130130382 Autoserum-containing bone marrow cell culture system, autoserum-containing bone marrow cell culture method, and method for producing medicinal composition comprising autoserum-containing cultured bone marrow cells as active ingredient |
| 05/23/2013 | US20130130381 Method for obtaining a population of stromal progenitor cells |
| 05/23/2013 | US20130130380 Platform of dendritic cell (dc)-based vaccination |
| 05/23/2013 | US20130130376 Screening methods, compositions identified thereby, tools useful for the identification thereof, and cell populations produced thereby |
| 05/23/2013 | US20130130375 Use of fibroblast growth factor for lineage priming and differentiation of pluripotent stem cells |
| 05/23/2013 | US20130130374 Cellular compositions and methods for their preparation and use |
| 05/23/2013 | US20130130373 Kit Comprising Serum Replacement and Labile Factors |
| 05/23/2013 | US20130130317 Method for producing substance |
| 05/23/2013 | US20130130297 Induction of a mature hepatocyte phenotype |
| 05/23/2013 | US20130130296 Modular Functional Peptides for Delivery of Nanoparticles |
| 05/23/2013 | US20130130263 Gametes separation methods, compositions and uses thereof |
| 05/23/2013 | US20130130236 Separation method of labeled cells and uses thereof |
| 05/23/2013 | US20130130233 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 05/23/2013 | US20130130223 Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters |
| 05/23/2013 | US20130129771 Regulatory immune cells with enhanced targeted cell death effect |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129708 Self-renewal promoter for neural stem cells and method for using same |
| 05/23/2013 | US20130129696 Human Stem Cell Materials and Methods |
| 05/23/2013 | US20130129692 Pluripotent cells |
| 05/23/2013 | US20130129691 Compositions For The Treatment Of Skin Conditions, Disorders Or Diseases And Methods Of Making And Using The Same |
| 05/23/2013 | US20130129687 Generation of Lineage-Restricted Progenitor Cells from Differentiated Cells |
| 05/23/2013 | CA2856127A1 Mutants of hydantoinase |
| 05/23/2013 | CA2856083A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 05/23/2013 | CA2856016A1 Agent for treating fibrosis of the intestine |
| 05/23/2013 | CA2855653A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | CA2852617A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/22/2013 | EP2594644A1 Method for preparing novel hipsc by means of mirna introduction |
| 05/22/2013 | EP2594643A1 Method for producing novel hipsc by means of sirna introduction |
| 05/22/2013 | EP2594637A1 Mutant polyhydroxyalkanoic acid synthase gene and method for producing aliphatic polyester using same |
| 05/22/2013 | EP2594636A2 Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same |
| 05/22/2013 | EP2594635A1 Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications |
| 05/22/2013 | EP2594634A1 Pancreatic islet separation method, and protective solution for protecting pancreatic islet tissue |
| 05/22/2013 | EP2594589A1 ANTI-Trop-2 ANTIBODY |
| 05/22/2013 | EP2594586A1 IL-31 monoclonal antibodies and methods of use |
| 05/22/2013 | EP2594583A1 Transferrin variants and conugates |
| 05/22/2013 | EP2594582A2 Peptide vaccines with Seq Id No: 110, 111, 387, 112, 394 114, 116, 117 or 121 for cancers expressing tumor-associated antigens |
| 05/22/2013 | EP2594581A2 Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens |
| 05/22/2013 | EP2593542A1 Methods of generating natural killer cells |
| 05/22/2013 | EP2593541A1 Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-a2 receptor antagonists |
| 05/22/2013 | EP2593126A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/22/2013 | EP2593116A1 Methods for increasing isolation yields of cellular products |
| 05/22/2013 | EP2593115A1 Treatment of t-cell mediated immune disorders |
| 05/22/2013 | EP2593114A1 Method of treating graft versus host disease |
| 05/22/2013 | EP2047867B1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |